Company Description
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally.
The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living.
It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device.
Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders.
The company sells its products through various sales channels, including orthotics and prosthetics providers, the veteran’s administration, and distributors.
Myomo, Inc. was incorporated in 2004 and is headquartered in Burlington, Massachusetts.
| Country | United States |
| Founded | 2004 |
| IPO Date | Jun 12, 2017 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 185 |
| CEO | Paul Gudonis |
Contact Details
Address: 45 Blue Sky Dr., Suite 101 Burlington, Massachusetts 01803 United States | |
| Phone | 617 996 9058 |
| Website | myomo.com |
Stock Details
| Ticker Symbol | MYO |
| Exchange | NYSEAMERICAN |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001369290 |
| CUSIP Number | 62857J201 |
| ISIN Number | US62857J2015 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Paul R. Gudonis | President, Chief Executive Officer and Chairman |
| David A. Henry | Chief Financial Officer |
| Dr. Harry Kovelman M.D. | Chief Medical Officer |
| Colin Anderson | Global Director of Operations |
| Joseph Chicoskie | Director of Marketing |
| Galina Shtivelman | Senior Director of Human Resources |
| Micah J. Mitchell | Chief Commercial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 25, 2025 | ARS | Filing |
| Apr 25, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 25, 2025 | DEF 14A | Other definitive proxy statements |
| Apr 10, 2025 | 8-K | Current Report |
| Mar 14, 2025 | 144 | Filing |
| Mar 13, 2025 | 144 | Filing |
| Mar 13, 2025 | 144 | Filing |
| Mar 13, 2025 | 144 | Filing |
| Mar 12, 2025 | 144 | Filing |
| Mar 10, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |